AHA 2021: PREPARE-IT 2 Fails To Show Significant Benefit for Icosapent Ethyl in Nonhospitalized Patients With COVID-19
Study author notes, however, that trends are in right direction and a larger randomized trial is needed
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.